Day: May 17, 2023

Voltalia SA: Information regarding the results of the vote on the resolutions presented at the Annual General Meeting on 17 May 2023

Voltalia SA: Information regarding the results of the vote on the resolutions presented at the Annual General Meeting on 17 May 2023

Information regarding the results of the vote on the resolutions presented at the Annual General Meeting on 17 May 2023 Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, held its Annual General Meeting today in Paris. A poll was held on each of the resolutions proposed. The results of the polls are set out below. Number of shareholders present, represented or voting by mail at the Ordinary General Meeting (OGM) : 948 Number of shareholders present, represented or voting by mail at the Extraordinary General Meeting (EGM):  948 Number of voting rights exercisable as of 17 May 2023: 197 184 767 Total votes represented in the vote on the resolutions submitted to OGM: 184 694 951 Total votes represented in the vote on the resolutions submitted to EGM: 184 694 951 Results of the polls on the...

Continue reading

AB Science summarizes key messages from its participation to a panel discussion at the 2023 ALS Drug Development Summit

AB Science summarizes key messages from its participation to a panel discussion at the 2023 ALS Drug Development Summit

  PRESS RELEASE AB SCIENCE SUMMARIZES KEY MESSAGES FROM ITS PARTICIPATION TO A PANEL DISCUSSION AT THE 2023 ALS DRUG DEVELOPMENT SUMMIT (BOSTON, USA) Paris, 17 May, 2023, 8:00pm CET AB Science SA (Euronext – FR0010557264 – AB) today summarizes the key messages delivered to an audience of key opinion leaders and decision-makers in the field of ALS research and healthcare policy, during an Panel Discussion at the ALS Drug Development Summit in Boston, USA (May 16-18, 2023). The Annual ALS Drug Development Summit is the only industry-focused conference dedicated to overcoming preclinical and clinical challenges currently facing ALS pipelines. Alain Moussy (CEO and co-founder of AB Science) was an invited panel member for a session entitled ‘A Year in Review: Showcasing the Breakthrough Developments in ALS Drug Development’. The themes of...

Continue reading

<div>BlueCat acquires Men&Mice to boost its industry-leading DNS, DHCP, and IP address management (DDI) platform</div>

BlueCat acquires Men&Mice to boost its industry-leading DNS, DHCP, and IP address management (DDI) platform

Enhanced portfolio will offer organizations of all sizes the tools to simplify and improve their networks TORONTO, May 17, 2023 (GLOBE NEWSWIRE) — BlueCat Networks, a leading provider of mission-critical network and cloud infrastructure software for reliable and secure DNS, DHCP, and IP address management (collectively known as DDI), today announced that it has acquired Men&Mice, which provides network management solutions. Regulators approved the deal. Financial terms were not disclosed. Men&Mice’s industry-recognized IP address management (IPAM) and orchestration solution, Micetro, strengthens BlueCat’s position as a DDI industry leader and further extends BlueCat’s mid-market offerings. BlueCat’s enhanced portfolio addresses the complex requirements of multi-cloud, hybrid cloud, and on-premises environments, which...

Continue reading

Blockmate Announces Debt Settlement

Blockmate Announces Debt Settlement

LONDON and AMSTERDAM, May 17, 2023 (GLOBE NEWSWIRE) — Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) announces that it has reached agreements with David Wong, Justin Rosenberg, Domenico Carosa, Georg Hochwimmer and Konstantin Lichtenwald, directors or officers of the Company, and two arms-length creditors (together, the “Creditors”) to settle (the “Debt Settlement”) outstanding indebtedness (the “Indebtedness”) totaling $141,538.03 through the issuance of 2,830,761 common shares at a deemed price of $0.05 per share. Completion of the Debt Settlement remains subject to the approval of the TSX Venture Exchange (the “Exchange”). All common shares issued in connection with the Debt Settlement will be subject to a four-month-and-one-day statutory holder period in accordance with applicable...

Continue reading

IZEA Expands AI Tools in IZEA Flex, Adds AI Briefs and AI Brainstorm

IZEA Expands AI Tools in IZEA Flex, Adds AI Briefs and AI Brainstorm

New Tools in IZEA Flex Use ChatGPT AI to Accelerate Campaign Ideation Process IZEA Expands AI Tools in IZEA Flex, Adds AI Briefs and AI Brainstorm New Tools in IZEA Flex Use ChatGPT AI to Accelerate Campaign Ideation Process New York, NY, May 17, 2023 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, announced today it has expanded its artificial intelligence (AI) toolset in IZEA Flex, its next-generation influencer marketing platform, with AI Briefs and AI Brainstorm — both powered by OpenAI’s ChatGPT technology. IZEA’s Founder and CEO, Ted Murphy, made the announcement during his presentation on the main stage at Adweek’s Social Media Week today. Murphy also unveiled a preview of IZEA Form, displaying the future...

Continue reading

Mayfair Gold Announces Closing of Flow-Through Financing and Arrangement of Common Share Financing

Mayfair Gold Announces Closing of Flow-Through Financing and Arrangement of Common Share Financing

VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) — Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today announced the closing of its previously announced private placement flow-through financing (the “FT Offering”) for proceeds of $6,001,600. The funds will be used to further the Company’s successful exploration program at the Fenn-Gib gold project in the Timmins region of Ontario. The Company issued 2,420,000 common shares on a flow-through basis (the “FT Shares”) at a price per FT Share of $2.48. The Offering price per FT share represents a premium of 37% over the closing price of Mayfair Gold common shares on the TSX.V on April 17, 2023. The FT Shares issued are subject to a four month hold period expiring on September 18, 2023. All proceeds from the sale of FT Shares will be used for expenditures...

Continue reading

Razor Energy Corp. Provides Alberta Wildfire Update and Production Impact

Razor Energy Corp. Provides Alberta Wildfire Update and Production Impact

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. CALGARY, Alberta, May 17, 2023 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor”) (TSXV: RZE) advises that, as a result of recent developments in the status of the Alberta wildfires, it has shut-in its operated and non-operated production in Kaybob and Swan Hills. The production impact is approximately 2,500 boe/d between the two areas. At this time it is unknown when this production will resume. Razor is not aware of any significant damage to the Company’s assets. Razor continues to work with local officials, regulators, and industry partners to ensure everyone’s safety in the area. The Company will provide another update to this evolving situation...

Continue reading

Ipsos acquires Shanghai Focus RX Research to strengthen its position in pharmaceutical research market in China

Ipsos acquires Shanghai Focus RX Research to strengthen its position in pharmaceutical research market in China

Ipsos acquires Shanghai Focus RX Researchto strengthen its position in pharmaceutical research market in China Paris, May 17th, 2023 – Ipsos is pleased to announce the acquisition of Shanghai Focus RX Research. The acquisition will significantly strengthen the expertise of Ipsos China’s Pharma Insights business and further support Ipsos’ Healthcare Insights business landscape. The company, established on 2008, is dedicated to the RX (prescription drugs) insight market, including policy and environment research, market expansion, product strategy research, marketing mix research and performance evaluation. Shanghai Focus RX has established a stable and high-quality client base with leading multinational pharmaceutical companies. The company’s team of 22 experts will become part of the Ipsos Healthcare Insights business....

Continue reading

PRESS RELEASE: NACON: A WORLD-FAMOUS FRANCHISE JOINS THE NACON CATALOGUE THIS YEAR

PRESS RELEASE: NACON: A WORLD-FAMOUS FRANCHISE JOINS THE NACON CATALOGUE THIS YEAR

         A WORLD-FAMOUS FRANCHISE JOINS THE NACON CATALOGUE THIS YEAR Lesquin, 17th of May 2023 – NACON is pleased to announce that they have signed a publishing and distribution agreement with Jumpgate AB and Les Editions Albert René for the game Asterix & Obelix: Heroes. Developed by the Jumpgate-studio gameXcite, the game will be available on PC and consoles, including Nintendo Switch™, in September 2023. Until now, the world-famous franchise had been absent from NACON’s catalogue, and as an expert in licensed games, NACON is therefore delighted to include it amongst their 2023 releases. For more than 60 years now, Asterix has delighted fans of all ages around the world. This is also the goal of Asterix & Obelix: Heroes, a game designed with everyone in mind, including gamers, thanks to this brand-new concept set in...

Continue reading

<div>Iceland Seafood International hf: Inflation and high volatility impacted Iceland Seafood's operation in Q1 2023</div>

Iceland Seafood International hf: Inflation and high volatility impacted Iceland Seafood’s operation in Q1 2023

Signs indicating a more balanced external environment is on the horizon Sales for Q1 2023: €123.1m, up 23% from Q1 2022 Net margin for Q1 2023: €9.8m, down €0.6m from Q1 2022 Normalised profit before tax in Q1 2023: €1.0m, compared with €2.6m Q1 2022 Net loss for Q1 2023: €2.2m compared with €0.8m loss in Q1 2022 Loss from discontinued operation (IS UK) in the period of €2.5m was in line with expectations Basic earnings per share (EPS) for Q1 2023 were negative by €0.0819 cents per thousand shares compared to negative €0.0279 cents per thousand shares for Q1 2022 Total assets of €305.3m at the end of March 2023 were €15.0m higher than at the beginning of the year. Equity ratio of 25.8% at the end of Q1 2023, Normalised PBT Outlook range for 2023 is revised to €7.5 – 11.5m The results of Iceland Seafood in Q1 2023 were marked by price...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.